Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.02 | 11.83 |
| PEG Ratio (TTM) | 0.00 | -11.83 |
| P/S Ratio (TTM) | 0.07 | 1.80 |
| P/B Ratio (TTM) | 1.97 | 3.78 |
| P/FCF Ratio (TTM) | 2.82 | 13.80 |
| Price to 5YR AVG Earnings Ratio | N/A | 21.31 |
| Price to 5YR AVG FCF Ratio | N/A | 12.00 |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 500.99% | 3.53% |
| ROE (TTM) | 10,076.67% | 28.83% |
| Net Profit Margin (TTM) | 320.64% | 6.75% |
| ROIC 5YR AVG | N/A | 8.11% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -151.37% | 432.46% | N/A |
| Revenue | -2.44% | 30.58% | N/A |
| Net Income | 184,645.30% | 476.52% | N/A |
| Cash Flow | 31.65% | 1,538.99% | N/A |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.80 | 3.79 |
| Quick Ratio (TTM) | 2.27 | 3.12 |
| D/E Ratio (TTM) | 4.01 | 1.82 |
| Interest Coverage (TTM) | 14.37 | 20.04 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 18.85 | 2.32 |
| LTL to 5YR AVG FCF | N/A | 7.20 |
| Shares Outstanding Growth 5YR AVG | N/A | -3.49% |